Article
Impact of a Cancer-Associated Mutation on Poly(ADP-ribose) Polymerase1 Inhibition
2024-11-15
Abstract excerpt
Poly(ADP-ribose) polymerase1 (PARP1) plays a vital role in DNA repair and its inhibition in cancer cells may cause cell apoptosis. In this study, we investigated the effects of a PARP1 variant, V762A, which is strongly associated with several cancers in humans, on the inhibition of PARP1 by three FDA approved inhibitors: niraparib, rucaparib and talazoparib. Our work suggests that these inhibitors bind to the V762...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 22d95329-e1ff-58b6-85ae-a1d89ad7e969
- DOI
- 10.1101/2024.11.13.623412
